Barclays PLC Opti Nose, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Barclays PLC holds 49,658 shares of OPTN stock, worth $23,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,658

Previous 49,658 -0.0%

Holding current value

$23,835

Previous $33,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$0.67 - $1.27 $14,453 - $27,396	-21,572 Reduced 30.28%	49,658 $33,000
Q2 2024 Aug 14, 2024	SELL	$0.82 - $1.44 $24,236 - $42,562	-29,557 Reduced 29.33%	71,230 $74,000
Q1 2024 May 15, 2024	SELL	$1.17 - $1.94 $57,318 - $95,040	-48,990 Reduced 32.71%	100,787 $147,000
Q4 2023 Feb 15, 2024	BUY	$1.02 - $1.47 $89,077 - $128,376	87,331 Added 139.85%	149,777 $193,000
Q3 2023 Nov 07, 2023	SELL	$0.93 - $1.38 $1,691 - $2,510	-1,819 Reduced 2.83%	62,446 $77,000
Q2 2023 Aug 03, 2023	BUY	$1.11 - $2.05 $7,429 - $13,720	6,693 Added 11.63%	64,265 $79,000
Q1 2023 May 04, 2023	SELL	$1.63 - $2.02 $29,595 - $36,677	-18,157 Reduced 23.98%	57,572 $111,000
Q4 2022 Feb 13, 2023	BUY	$1.68 - $3.7 $36,247 - $79,831	21,576 Added 39.84%	75,729 $140,000
Q3 2022 Nov 03, 2022	SELL	$3.43 - $4.01 $30,369 - $35,504	-8,854 Reduced 14.05%	54,153 $198,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.82 $7,414 - $16,093	-4,213 Reduced 6.27%	63,007 $231,000
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $7,861 - $15,723	-5,072 Reduced 7.02%	67,220 $109,000
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.16 $160,765 - $216,178	68,411 Added 1762.72%	72,292 $217,000
Q2 2021 Aug 13, 2021	SELL	$2.91 - $3.83 $73,841 - $97,186	-25,375 Reduced 86.73%	3,881 $12,000
Q1 2021 May 13, 2021	BUY	$3.47 - $4.75 $62,241 - $85,200	17,937 Added 158.47%	29,256 $107,000
Q4 2020 Feb 11, 2021	SELL	$3.2 - $4.98 $14,598 - $22,718	-4,562 Reduced 28.73%	11,319 $47,000
Q3 2020 Nov 12, 2020	SELL	$3.69 - $7.09 $16,077 - $30,891	-4,357 Reduced 21.53%	15,881 $62,000
Q2 2020 Aug 12, 2020	BUY	$3.58 - $7.44 $28,486 - $59,200	7,957 Added 64.79%	20,238 $151,000
Q1 2020 May 13, 2020	SELL	$3.49 - $9.2 $55,400 - $146,040	-15,874 Reduced 56.38%	12,281 $55,000
Q4 2019 Feb 10, 2020	BUY	$6.27 - $11.41 $94,507 - $171,982	15,073 Added 115.22%	28,155 $260,000
Q3 2019 Nov 14, 2019	SELL	$4.75 - $8.38 $14,178 - $25,014	-2,985 Reduced 18.58%	13,082 $92,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $65,555 - $112,058	10,243 Added 175.88%	16,067 $114,000
Q1 2019 May 15, 2019	BUY	$6.1 - $10.3 $35,526 - $59,987	5,824 New	5,824 $60,000
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $64,888 - $132,443	-11,111 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $53,871 - $128,979	4,334 Added 63.95%	11,111 $138,000
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $105,937 - $160,799	5,650 Added 501.33%	6,777 $189,000
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $4,232 - $5,538	266 Added 30.89%	1,127 $22,000
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $13,087 - $17,874	861	861 $16,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account